Cargando…

Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson’s Disease: An Influence of Chronic Pramipexole in Rats

Our recent study has indicated that a moderate lesion of the mesostriatal and mesolimbic pathways in rats, modelling preclinical stages of Parkinson’s disease, induces a depressive-like behaviour which is reversed by chronic treatment with pramipexole. The purpose of the present study was to examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghauzen-Maciejewska, Klemencja, Wardas, Jadwiga, Kosmowska, Barbara, Głowacka, Urszula, Kuter, Katarzyna, Ossowska, Krystyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349741/
https://www.ncbi.nlm.nih.gov/pubmed/25739024
http://dx.doi.org/10.1371/journal.pone.0117698
_version_ 1782360075646533632
author Berghauzen-Maciejewska, Klemencja
Wardas, Jadwiga
Kosmowska, Barbara
Głowacka, Urszula
Kuter, Katarzyna
Ossowska, Krystyna
author_facet Berghauzen-Maciejewska, Klemencja
Wardas, Jadwiga
Kosmowska, Barbara
Głowacka, Urszula
Kuter, Katarzyna
Ossowska, Krystyna
author_sort Berghauzen-Maciejewska, Klemencja
collection PubMed
description Our recent study has indicated that a moderate lesion of the mesostriatal and mesolimbic pathways in rats, modelling preclinical stages of Parkinson’s disease, induces a depressive-like behaviour which is reversed by chronic treatment with pramipexole. The purpose of the present study was to examine the role of brain derived neurotrophic factor (BDNF) signalling in the aforementioned model of depression. Therefore, we investigated the influence of 6-hydoxydopamine (6-OHDA) administration into the ventral region of the caudate-putamen on mRNA levels of BDNF and tropomyosin-related kinase B (trkB) receptor. The BDNF and trkB mRNA levels were determined in the nigrostriatal and limbic structures by in situ hybridization 2 weeks after the operation. Pramipexole (1 mg/kg sc twice a day) and imipramine (10 mg/kg ip once a day) were injected for 2 weeks. The lesion lowered the BDNF and trkB mRNA levels in the hippocampus [CA1, CA3 and dentate gyrus (DG)] and amygdala (basolateral/lateral) as well as the BDNF mRNA content in the habenula (medial/lateral). The lesion did not influence BDNF and trkB expression in the caudate-putamen, substantia nigra, nucleus accumbens (shell and core) and ventral tegmental area (VTA). Chronic imipramine reversed the lesion-induced decreases in BDNF mRNA in the DG. Chronic pramipexole increased BDNF mRNA, but decreased trkB mRNA in the VTA in lesioned rats. Furthermore, it reduced BDNF and trkB mRNA expression in the shell and core of the nucleus accumbens, BDNF mRNA in the amygdala and trkB mRNA in the caudate-putamen in these animals. The present study indicates that both the 6-OHDA-induced dopaminergic lesion and chronic pramipexole influence BDNF signalling in limbic structures, which may be related to their pro-depressive and antidepressant activity in rats, respectively.
format Online
Article
Text
id pubmed-4349741
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43497412015-03-17 Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson’s Disease: An Influence of Chronic Pramipexole in Rats Berghauzen-Maciejewska, Klemencja Wardas, Jadwiga Kosmowska, Barbara Głowacka, Urszula Kuter, Katarzyna Ossowska, Krystyna PLoS One Research Article Our recent study has indicated that a moderate lesion of the mesostriatal and mesolimbic pathways in rats, modelling preclinical stages of Parkinson’s disease, induces a depressive-like behaviour which is reversed by chronic treatment with pramipexole. The purpose of the present study was to examine the role of brain derived neurotrophic factor (BDNF) signalling in the aforementioned model of depression. Therefore, we investigated the influence of 6-hydoxydopamine (6-OHDA) administration into the ventral region of the caudate-putamen on mRNA levels of BDNF and tropomyosin-related kinase B (trkB) receptor. The BDNF and trkB mRNA levels were determined in the nigrostriatal and limbic structures by in situ hybridization 2 weeks after the operation. Pramipexole (1 mg/kg sc twice a day) and imipramine (10 mg/kg ip once a day) were injected for 2 weeks. The lesion lowered the BDNF and trkB mRNA levels in the hippocampus [CA1, CA3 and dentate gyrus (DG)] and amygdala (basolateral/lateral) as well as the BDNF mRNA content in the habenula (medial/lateral). The lesion did not influence BDNF and trkB expression in the caudate-putamen, substantia nigra, nucleus accumbens (shell and core) and ventral tegmental area (VTA). Chronic imipramine reversed the lesion-induced decreases in BDNF mRNA in the DG. Chronic pramipexole increased BDNF mRNA, but decreased trkB mRNA in the VTA in lesioned rats. Furthermore, it reduced BDNF and trkB mRNA expression in the shell and core of the nucleus accumbens, BDNF mRNA in the amygdala and trkB mRNA in the caudate-putamen in these animals. The present study indicates that both the 6-OHDA-induced dopaminergic lesion and chronic pramipexole influence BDNF signalling in limbic structures, which may be related to their pro-depressive and antidepressant activity in rats, respectively. Public Library of Science 2015-03-04 /pmc/articles/PMC4349741/ /pubmed/25739024 http://dx.doi.org/10.1371/journal.pone.0117698 Text en © 2015 Berghauzen-Maciejewska et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Berghauzen-Maciejewska, Klemencja
Wardas, Jadwiga
Kosmowska, Barbara
Głowacka, Urszula
Kuter, Katarzyna
Ossowska, Krystyna
Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson’s Disease: An Influence of Chronic Pramipexole in Rats
title Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson’s Disease: An Influence of Chronic Pramipexole in Rats
title_full Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson’s Disease: An Influence of Chronic Pramipexole in Rats
title_fullStr Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson’s Disease: An Influence of Chronic Pramipexole in Rats
title_full_unstemmed Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson’s Disease: An Influence of Chronic Pramipexole in Rats
title_short Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson’s Disease: An Influence of Chronic Pramipexole in Rats
title_sort alterations of bdnf and trkb mrna expression in the 6-hydroxydopamine-induced model of preclinical stages of parkinson’s disease: an influence of chronic pramipexole in rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349741/
https://www.ncbi.nlm.nih.gov/pubmed/25739024
http://dx.doi.org/10.1371/journal.pone.0117698
work_keys_str_mv AT berghauzenmaciejewskaklemencja alterationsofbdnfandtrkbmrnaexpressioninthe6hydroxydopamineinducedmodelofpreclinicalstagesofparkinsonsdiseaseaninfluenceofchronicpramipexoleinrats
AT wardasjadwiga alterationsofbdnfandtrkbmrnaexpressioninthe6hydroxydopamineinducedmodelofpreclinicalstagesofparkinsonsdiseaseaninfluenceofchronicpramipexoleinrats
AT kosmowskabarbara alterationsofbdnfandtrkbmrnaexpressioninthe6hydroxydopamineinducedmodelofpreclinicalstagesofparkinsonsdiseaseaninfluenceofchronicpramipexoleinrats
AT głowackaurszula alterationsofbdnfandtrkbmrnaexpressioninthe6hydroxydopamineinducedmodelofpreclinicalstagesofparkinsonsdiseaseaninfluenceofchronicpramipexoleinrats
AT kuterkatarzyna alterationsofbdnfandtrkbmrnaexpressioninthe6hydroxydopamineinducedmodelofpreclinicalstagesofparkinsonsdiseaseaninfluenceofchronicpramipexoleinrats
AT ossowskakrystyna alterationsofbdnfandtrkbmrnaexpressioninthe6hydroxydopamineinducedmodelofpreclinicalstagesofparkinsonsdiseaseaninfluenceofchronicpramipexoleinrats